세계의 섬유아세포 성장인자 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(-2031년) - 제품별, 용도별, 최종사용자별, 지역별

Fibroblast Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

US $ 4,995 ￦ 6,879,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,699,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,598,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 섬유아세포 성장인자(FGF) 시장 규모는 2024년 2억 8,000만 달러에 달할 것으로 예상되며, 향후 10년간 강력한 성장세를 보일 것으로 예상됩니다. 이 시장은 향후 8.64%의 CAGR로 확대되어 2031년 말에는 5억 달러에 달할 것으로 예상됩니다. FGF는 세포 증식, 분화, 상처 치유, 조직 유지에 매우 중요한 역할을 하며, 다양한 의료 응용 분야에서 매우 중요한 역할을 하고 있습니다.

FGF는 특히 피부, 근육, 힘줄, 뼈, 치아, 신경과 같은 조직의 재생과 치유에 있어 의료 치료에서 그 중요성이 커지고 있으며, FGF를 줄기세포 및 특수 소재와 결합하면 부상이나 질병으로부터의 회복 과정에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다.

분자과학의 발전으로 상처 치유 메커니즘에 대한 종합적인 이해가 이루어지고 있습니다. 이러한 지식은 흉터 없는 상처 치유와 줄기세포 전구체로부터의 조직 이식을 위한 길을 열어 환자 치료를 개선할 수 있을 것으로 기대됩니다.

미국에서는 다양한 암이 급증하고 있으며, 특히 암 치료에서 FGF에 대한 수요가 급증하고 있습니다. 유방암과 위암의 유행이 이 수요에 크게 기여하고 있습니다.

독일은 생명공학 및 재생의료의 최전선에 있으며, FGF의 혁신 가능성에 주목하고 있습니다. 특히 만성 상처, 근골격계 질환, 신경 질환의 치료에서 학계, 생명공학 기업, 정부 기관의 공동 연구가 FGF의 수요를 주도하고 있습니다.

이 보고서는 세계 섬유아세포 성장인자 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아의 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 섬유아세포 성장인자 시장 전망, 2018-2031년

• 세계의 섬유아세포 성장인자 시장 전망, 제품별, 금액(100만 달러), 2018-2031년
• 세계의 섬유아세포 성장인자 시장 전망, 용도별, 금액(100만 달러), 2018-2031년
• 세계의 섬유아세포 성장인자 시장 전망, 최종사용자별, 금액(100만 달러), 2018-2031년
• 세계의 섬유아세포 성장인자 시장 전망, 지역별, 금액(100만 달러), 2018-2031년

제4장 북미의 섬유아세포 성장인자 시장 전망, 2018-2031년

제5장 유럽의 섬유아세포 성장인자 시장 전망, 2018-2031년

제6장 아시아태평양의 섬유아세포 성장인자 시장 전망, 2018-2031년

제7장 라틴아메리카의 섬유아세포 성장인자 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 섬유아세포 성장인자 시장 전망, 2018-2031년

제9장 경쟁 상황

• 최종사용자별과 용도별 히트맵
• 기업의 시장 점유율 분석, 2023년
• 경쟁력 대시보드
• 기업 개요
  • Thermo Fisher Scientific
  • Sigma-Aldrich(now part of Merck KGaA)
  • PeproTech
  • R&D Systems(a Bio-Techne brand)
  • Abcam
  • Cell Signaling Technology
  • Novus Biologicals

제10장 부록

ksm

영문 목차

영문목차

The global fibroblast growth factors (FGFs) market, which was valued at $280 million in 2024, is expected to experience robust growth over the next decade, with a projected CAGR of 8.64%. By the end of 2031, the market is anticipated to reach a valuation of $500 million. FGFs play a pivotal role in cellular proliferation, differentiation, wound healing, and tissue maintenance, making them crucial in various medical applications.

The Rising Significance of FGFs in the Medical Field

FGFs have gained increasing importance in medical treatments, particularly in regenerating and healing tissues such as skin, muscles, tendons, bones, teeth, and nerves. The combination of FGFs with stem cells and specialized materials holds the potential to revolutionize the recovery process from injuries and diseases.

Factors Boosting the Importance of Fibroblast Growth Factors

In-Depth Understanding of Wound Healing Mechanisms: Advances in molecular science have led to a comprehensive understanding of wound healing mechanisms. This knowledge is expected to pave the way for scar-free wound healing and tissue transplantation from stem cell precursors, enhancing patient care.

Challenges Hindering Sales Growth of Fibroblast Growth Factors

High Development and Production Costs: The complex process of developing and producing FGFs involves significant financial investments. From extensive research to preclinical testing and clinical trials, the costs associated with FGF development pose challenges to their widespread adoption.

Country-Specific Insights

United States: The United States is experiencing a surge in various carcinomas, driving the demand for FGFs, especially in cancer treatment. The prevalence of breast and stomach cancers has significantly contributed to this demand.

According to the American Society of Clinical Oncology (ASCO), approximately 297,790 women in the U.S. are expected to be diagnosed with invasive breast cancer in 2023. Additionally, stomach cancer cases are projected to reach around 26,500, with 15,930 in men and 10,570 in women in 2022.

The need for fibroblast growth factors and cytokines in the treatment of various carcinomas, coupled with government initiatives to promote research, is propelling the demand for FGFs in the United States.

Germany: Germany is at the forefront of biotechnology and regenerative medicine, focusing on the transformative potential of FGFs. Collaborations between academia, biotech companies, and government bodies are driving demand for FGFs, particularly in the treatment of chronic wounds, musculoskeletal disorders, and neurological conditions.

China: FGFs are emerging as promising targets for cancer treatment in China. Researchers are exploring FGFs' potential to disrupt tumor growth and angiogenesis, offering new avenues for cancer therapies. The country's robust biopharmaceutical industry and collaborative research initiatives are accelerating the development of FGF-targeted therapies.

Competition Landscape

The global fibroblast growth factors market is characterized by a consolidated competitive landscape, with a few key players offering products and services on a global scale. Companies in this market are focusing on research and development, product launches, and strategic mergers to meet customer expectations and strengthen their market position.

Key Companies in the Market

• Thermo Fisher Scientific
• Sigma-Aldrich (now part of Merck KGaA)
• PeproTech
• R&D Systems (a Bio-Techne brand)
• Abcam
• Cell Signaling Technology
• Novus Biologicals

Key Segments of Fibroblast Growth Factors Industry Research

Product:

• FGF1
• FGF2
• FGF3
• FGF4
• FGF7
• FGF10
• FGF11
• FGF12
• FGF13
• FGF14
• FGF15
• FGF18
• FGF19
• FGF20
• FGF23
• Others

Application:

• Oncology
• Hematology
• Wound Healing
• Dermatology
• Cardiovascular Disease & Diabetes
• Cell Culture
• Others

End User:

• Pharmaceutical & Biotechnology Companies
• Research Centers & Academic Institutes
• CMOs & CDMOs

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Fibroblast Growth Factors Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 3.1. Global Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. FGF1
    • 3.1.1.2. FGF2
    • 3.1.1.3. FGF3
    • 3.1.1.4. FGF4
    • 3.1.1.5. FGF7
    • 3.1.1.6. FGF10
    • 3.1.1.7. FGF11
    • 3.1.1.8. FGF12
    • 3.1.1.9. FGF13
    • 3.1.1.10. FGF14
    • 3.1.1.11. FGF15
    • 3.1.1.12. FGF18
    • 3.1.1.13. FGF19
    • 3.1.1.14. FGF20
    • 3.1.1.15. FGF23
    • 3.1.1.16. Others
• 3.2. Global Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Oncology
    • 3.2.1.2. Hematology
    • 3.2.1.3. Wound Healing
    • 3.2.1.4. Dermatology
    • 3.2.1.5. Cardiovascular Disease & Diabetes
    • 3.2.1.6. Cell Culture
    • 3.2.1.7. Others
• 3.3. Global Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. Pharmaceutical & Biotechnology Companies
    • 3.3.1.2. Research Centers & Academic Institutes
    • 3.3.1.3. CMOs & CDMOs
• 3.4. Global Fibroblast Growth Factors Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
  • 3.4.1. Key Highlights
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. Asia Pacific
    • 3.4.1.4. Latin America
    • 3.4.1.5. Middle East & Africa

4. North America Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 4.1. North America Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. FGF1
    • 4.1.1.2. FGF2
    • 4.1.1.3. FGF3
    • 4.1.1.4. FGF4
    • 4.1.1.5. FGF7
    • 4.1.1.6. FGF10
    • 4.1.1.7. FGF11
    • 4.1.1.8. FGF12
    • 4.1.1.9. FGF13
    • 4.1.1.10. FGF14
    • 4.1.1.11. FGF15
    • 4.1.1.12. FGF18
    • 4.1.1.13. FGF19
    • 4.1.1.14. FGF20
    • 4.1.1.15. FGF23
    • 4.1.1.16. Others
• 4.2. North America Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Oncology
    • 4.2.1.2. Hematology
    • 4.2.1.3. Wound Healing
    • 4.2.1.4. Dermatology
    • 4.2.1.5. Cardiovascular Disease & Diabetes
    • 4.2.1.6. Cell Culture
    • 4.2.1.7. Others
• 4.3. North America Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Pharmaceutical & Biotechnology Companies
    • 4.3.1.2. Research Centers & Academic Institutes
    • 4.3.1.3. CMOs & CDMOs
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis
• 4.4. North America Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S. Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 4.4.1.2. U.S. Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 4.4.1.3. U.S. Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.1.4. Canada Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 4.4.1.5. Canada Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 4.4.1.6. Canada Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
  • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 5.1. Europe Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. FGF1
    • 5.1.1.2. FGF2
    • 5.1.1.3. FGF3
    • 5.1.1.4. FGF4
    • 5.1.1.5. FGF7
    • 5.1.1.6. FGF10
    • 5.1.1.7. FGF11
    • 5.1.1.8. FGF12
    • 5.1.1.9. FGF13
    • 5.1.1.10. FGF14
    • 5.1.1.11. FGF15
    • 5.1.1.12. FGF18
    • 5.1.1.13. FGF19
    • 5.1.1.14. FGF20
    • 5.1.1.15. FGF23
    • 5.1.1.16. Others
• 5.2. Europe Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Oncology
    • 5.2.1.2. Hematology
    • 5.2.1.3. Wound Healing
    • 5.2.1.4. Dermatology
    • 5.2.1.5. Cardiovascular Disease & Diabetes
    • 5.2.1.6. Cell Culture
    • 5.2.1.7. Others
• 5.3. Europe Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Pharmaceutical & Biotechnology Companies
    • 5.3.1.2. Research Centers & Academic Institutes
    • 5.3.1.3. CMOs & CDMOs
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis
• 5.4. Europe Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. Germany Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.2. Germany Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.3. Germany Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.4. U.K. Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.5. U.K. Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.6. U.K. Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.7. France Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.8. France Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.9. France Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.10. Italy Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.11. Italy Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.12. Italy Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.13. Turkey Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.14. Turkey Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.15. Turkey Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.16. Russia Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.17. Russia Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.18. Russia Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.19. Rest of Europe Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.4.1.20. Rest of Europe Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.21. Rest of Europe Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. FGF1
    • 6.1.1.2. FGF2
    • 6.1.1.3. FGF3
    • 6.1.1.4. FGF4
    • 6.1.1.5. FGF7
    • 6.1.1.6. FGF10
    • 6.1.1.7. FGF11
    • 6.1.1.8. FGF12
    • 6.1.1.9. FGF13
    • 6.1.1.10. FGF14
    • 6.1.1.11. FGF15
    • 6.1.1.12. FGF18
    • 6.1.1.13. FGF19
    • 6.1.1.14. FGF20
    • 6.1.1.15. FGF23
    • 6.1.1.16. Others
• 6.2. Asia Pacific Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Oncology
    • 6.2.1.2. Hematology
    • 6.2.1.3. Wound Healing
    • 6.2.1.4. Dermatology
    • 6.2.1.5. Cardiovascular Disease & Diabetes
    • 6.2.1.6. Cell Culture
    • 6.2.1.7. Others
• 6.3. Asia Pacific Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Pharmaceutical & Biotechnology Companies
    • 6.3.1.2. Research Centers & Academic Institutes
    • 6.3.1.3. CMOs & CDMOs
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. Asia Pacific Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. China Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.2. China Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.3. China Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.4. Japan Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.5. Japan Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.6. Japan Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.7. South Korea Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.8. South Korea Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.9. South Korea Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.10. India Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.11. India Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.12. India Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.13. Southeast Asia Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.14. Southeast Asia Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.15. Southeast Asia Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.16. Rest of Asia Pacific Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.4.1.17. Rest of Asia Pacific Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.18. Rest of Asia Pacific Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 7.1. Latin America Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. FGF1
    • 7.1.1.2. FGF2
    • 7.1.1.3. FGF3
    • 7.1.1.4. FGF4
    • 7.1.1.5. FGF7
    • 7.1.1.6. FGF10
    • 7.1.1.7. FGF11
    • 7.1.1.8. FGF12
    • 7.1.1.9. FGF13
    • 7.1.1.10. FGF14
    • 7.1.1.11. FGF15
    • 7.1.1.12. FGF18
    • 7.1.1.13. FGF19
    • 7.1.1.14. FGF20
    • 7.1.1.15. FGF23
    • 7.1.1.16. Others
• 7.2. Latin America Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 7.2.1.1. Oncology
  • 7.2.1.2. Hematology
  • 7.2.1.3. Wound Healing
  • 7.2.1.4. Dermatology
  • 7.2.1.5. Cardiovascular Disease & Diabetes
  • 7.2.1.6. Cell Culture
  • 7.2.1.7. Others
• 7.3. Latin America Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Pharmaceutical & Biotechnology Companies
    • 7.3.1.2. Research Centers & Academic Institutes
    • 7.3.1.3. CMOs & CDMOs
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Latin America Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Brazil Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.4.1.2. Brazil Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.3. Brazil Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.4. Mexico Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.4.1.5. Mexico Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.6. Mexico Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.7. Argentina Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.4.1.8. Argentina Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.9. Argentina Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.10. Rest of Latin America Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.4.1.11. Rest of Latin America Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.12. Rest of Latin America Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Fibroblast Growth Factors Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. FGF1
    • 8.1.1.2. FGF2
    • 8.1.1.3. FGF3
    • 8.1.1.4. FGF4
    • 8.1.1.5. FGF7
    • 8.1.1.6. FGF10
    • 8.1.1.7. FGF11
    • 8.1.1.8. FGF12
    • 8.1.1.9. FGF13
    • 8.1.1.10. FGF14
    • 8.1.1.11. FGF15
    • 8.1.1.12. FGF18
    • 8.1.1.13. FGF19
    • 8.1.1.14. FGF20
    • 8.1.1.15. FGF23
    • 8.1.1.16. Others
• 8.2. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Oncology
    • 8.2.1.2. Hematology
    • 8.2.1.3. Wound Healing
    • 8.2.1.4. Dermatology
    • 8.2.1.5. Cardiovascular Disease & Diabetes
    • 8.2.1.6. Cell Culture
    • 8.2.1.7. Others
• 8.3. Middle East & Africa Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Pharmaceutical & Biotechnology Companies
    • 8.3.1.2. Research Centers & Academic Institutes
    • 8.3.1.3. CMOs & CDMOs
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. GCC Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.4.1.2. GCC Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.3. GCC Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.4. South Africa Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.4.1.5. South Africa Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.6. South Africa Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.7. Egypt Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.4.1.8. Egypt Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.9. Egypt Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.10. Nigeria Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.4.1.11. Nigeria Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.12. Nigeria Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.13. Rest of Middle East & Africa Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.4.1.14. Rest of Middle East & Africa Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.15. Rest of Middle East & Africa Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. By End User vs by Application Heatmap
• 9.2. Company Market Share Analysis, 2023
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Thermo Fisher Scientific
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Sigma-Aldrich (now part of Merck KGaA)
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. PeproTech
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. R&D Systems (a Bio-Techne brand)
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. Abcam
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. Cell Signaling Technology
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. Novus Biologicals
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료